Method of treating attention deficit disorders with d-threo methylphenidate

  • US 5,908,850 A
  • Filed: 04/02/1997
  • Issued: 06/01/1999
  • Est. Priority Date: 12/04/1995
  • Status: Expired due to Term
First Claim
Patent Images

1. A method of treating at least one of Attention Deficit Disorder and Attention Deficit Hyperactivity Disorder and providing enhanced therapeutic activity, reduced side effects euphoric effect, or potential for drug abuse as compared to racemic threo methylphenidate, said method comprising administering to a human exhibiting symptoms of such disorder therapeutically effective amounts of D-threo methylphenidate or pharmaceutically acceptable salt thereof, substantially free of L-threo methylphenidate, on a daily basis.

View all claims

    Thank you for your feedback